Honoring 50 Years of Clinical Heart Transplantation in Circulation In-Depth State-of-the-Art Review
J Stehlik, J Kobashigawa, SA Hunt, H Reichenspurner… - Circulation, 2018 - Am Heart Assoc
Heart transplantation has become a standard therapy option for advanced heart failure. The
translation of heart transplantation from innovative experiments to long-term clinical success …
translation of heart transplantation from innovative experiments to long-term clinical success …
[HTML][HTML] The past, present and future of heart transplantation
IC Kim, JC Youn… - Korean circulation journal, 2018 - synapse.koreamed.org
Heart transplantation (HTx) has become standard treatment for selected patients with end-
stage heart failure. Improvements in immunosuppressant, donor procurement, surgical …
stage heart failure. Improvements in immunosuppressant, donor procurement, surgical …
The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-fifth adult heart transplantation report …
KK Khush, WS Cherikh, DC Chambers… - The Journal of Heart …, 2018 - jhltonline.org
The past year has been notable for the multiple celebrations and symposia around the globe
commemorating the first heart transplant ever performed by Dr. Christiaan Barnard at Groote …
commemorating the first heart transplant ever performed by Dr. Christiaan Barnard at Groote …
3ª diretriz brasileira de transplante cardíaco
F Bacal, FG Marcondes-Braga, LEP Rohde… - Arquivos brasileiros de …, 2018 - SciELO Brasil
Prezados colegas, Grandes avanços no diagnóstico, monitorização e tratamento da
Insuficiência Cardíaca (IC) foram observados nos últimos anos, com impactos reais na …
Insuficiência Cardíaca (IC) foram observados nos últimos anos, com impactos reais na …
Long-term sirolimus for primary immunosuppression in heart transplant recipients
R Asleh, A Briasoulis, WK Kremers, R Adigun… - Journal of the American …, 2018 - jacc.org
Background: Small studies have reported superiority of sirolimus (SRL) over calcineurin
inhibitor (CNI) in mitigating cardiac allograft vasculopathy (CAV) after heart transplantation …
inhibitor (CNI) in mitigating cardiac allograft vasculopathy (CAV) after heart transplantation …
Nanomedicine approaches for sirolimus delivery: a review of pharmaceutical properties and preclinical studies
Sirolimus (rapamycin) is a mammalian target of rapamycin (mTOR) inhibitor with
immunosuppressive, antiproliferative, antiangiogenic, antifungal, anti-restenosis and anti …
immunosuppressive, antiproliferative, antiangiogenic, antifungal, anti-restenosis and anti …
Reduced myocardial flow reserve by positron emission tomography predicts cardiovascular events after cardiac transplantation
MC Konerman, JJ Lazarus, RL Weinberg… - Circulation: Heart …, 2018 - Am Heart Assoc
Background: We evaluated the diagnostic and prognostic value of quantification of
myocardial flow reserve (MFR) with positron emission tomography (PET) in orthotopic heart …
myocardial flow reserve (MFR) with positron emission tomography (PET) in orthotopic heart …
Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: a meta-analysis
DL Jennings, N Lange, M Shullo, F Latif… - International journal of …, 2018 - Elsevier
Background Data evaluating mTOR inhibitor use heart transplant (HT) patients comes from
relatively small studies and controversy exists regarding their specific role. We performed a …
relatively small studies and controversy exists regarding their specific role. We performed a …
Cardiac allograft vasculopathy: A review
Cardiac allograft vasculopathy (CAV) is a complex disease that remains a significant cause
of morbidity and mortality after orthotopic heart transplantation (OHT). Originating as a result …
of morbidity and mortality after orthotopic heart transplantation (OHT). Originating as a result …
Optimizing the safety profile of everolimus by delayed initiation in de novo heart transplant recipients: results of the prospective randomized study EVERHEART
Background Although everolimus potentially improves long-term heart transplantation (HTx)
outcomes, its early postoperative safety profile had raised concerns and needs optimization …
outcomes, its early postoperative safety profile had raised concerns and needs optimization …